Fredri Edenius

Phagenesis Ltd. develops a treatment for dysphagia. Its product Phagenyx consists of a base station and a treatment catheter which in combination enable the healthcare professional to deliver personalized dysphagia treatment for every patient. The company was founded by Conor Joseph Mulrooney and Shaheen Hamdy in 2007 and is headquartered in Manchester, the United Kingdom.

The British company focuses on researching the gut microbiome to improve human health. Ateria Health Ltd. has developed a food supplement called Juvia™ Digestive Balance Formula, which is activated by their unique ingredient ERME™. Neil David Wickers has been the CEO of the company since 2021.

Anglo Scientific Ltd (Anglo Scientific) is a venture capital firm founded in 2000 by Douglas Dundonald and Henry Hyde Thomson. The firm is headquartered in Ledbury, United Kingdom.

Phasor Solutions Ltd. engages in the design and development of flat panel phased array antennas. The company was founded by Richard Hammond Mayo, Douglas Dundonald, and Henry Charles Anthony Hyde-Thomson in 2005 and is headquartered in London, the United Kingdom.

Solus Scientific Solutions Ltd. provides diagnostics and microbiological testing services. Its products encompass pathogens, Allergens, and Meat Species Identification. The company was founded by Stewart Wallace and William H. Stimson in June 2009 and is headquartered in Mansfield, the United Kingdom.

On-Sun Systems Ltd. develops and manufactures concentrated photovoltaic panels to commercial and residential rooftop applications. Its product is a direct alternative to standard rooftop photovoltaic panels, based on an innovative tracking mechanism and provides low cost tracking mechanism for concentrated photovoltaic for use in flat, inexpensive panels. The company's concentrated photovoltaic solar panels is focus sunlight onto a small photovoltaic chip and remove the need for large areas of expensive material while enabling conversion efficiencies. The firm's technology enables solar installations to generate substantially energy per site. On-Sun Systems was founded on January 28, 2010 by Andrew Tomlinson, John-Paul Szczepanik and Gregory Finn and is headquartered in Ledbury, the United Kingdom.

Apta Biosciences Ltd. develops and commercializes synthetic antibody alternatives. It is a synthetic biology company specialized in developing unique, proprietary molecules that can be used broadly across diagnostics and therapeutics to facilitate and expand scientific discovery enabling the development of new healthcare solutions. The company was founded by Fredrik Edenius, William Addison and Shozo Fujita in 2013 and is headquartered in London, the United Kingdom.